Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

The FTC is putting these three drug stocks at risk by trying to strip their therapies of protection from generics.

The post Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• It doesn’t matter if you have $500 or $5 million. Do this now.